Gilead SciencesGILD.OValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Richly Valued” zone.
As of Oct 16, 2026, Gilead Sciences (GILD.O) trades at a negative P/E (-59.77x, due to a recent net loss), P/B of 16.40x, P/S of 6.36x, and a dividend yield of 1.58%.
Longitudinal percentile comparison: P/E historical percentile is still accumulating data over the trailing long-term window (vs. the short-term percentile still accumulating data); P/B sits at the 100th percentile over the trailing 10Y window (vs. 100th percentile over 3Y); P/S sits at the 99th percentile over the trailing 10Y window (vs. 98th percentile over 3Y).
Cross-sectional valuation: its P/B ranks at the 94th percentile within its industry and the 95th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 2.57%, ranking at the 23rd percentile over the trailing 20Y window.
Its P/B percentile is roughly the same whether measured against the industry or the broader market. Of the 2.57% total shareholder yield, 1.58% is paid out as dividends and roughly 0.99% is implied to come from buybacks — both channels are meaningfully in play. Gilead Sciences operates in the Manufacturing sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NASDAQ: GILD · GILD
Want the full picture on whether Gilead Sciences (GILD.O) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | -59.77 | Negative | Negative | Negative | Negative | Negative | Negative |
| P/B (MRQ) | 16.40 | ||||||
| P/S (TTM) | 6.36 | ||||||
| Dividend Yield | 1.58% | ||||||
| Buyback + Div Yield | 2.57% |